Cargando…
Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study
Background: Variability still exist about the growth response to growth hormone (GH) therapy in children with idiopathic short stature (ISS). We describe the growth response to rhGH therapy for >2 years in 20 prepubertal children with idiopathic short stature (ISS) and 18 children with GH deficie...
Autores principales: | Soliman, Ashraf T, Elawwa, Ahmed, Itani, Maya, Jour, Celine, De Sanctis, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233685/ https://www.ncbi.nlm.nih.gov/pubmed/31544806 http://dx.doi.org/10.23750/abm.v90i8-S.8506 |
Ejemplares similares
-
GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy
por: Savage, Martin O., et al.
Publicado: (2021) -
Decreased Thyroxine Levels during rhGH Therapy in Children with Growth Hormone Deficiency
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2021) -
Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1
por: Felício, João Soares, et al.
Publicado: (2019) -
Safety of Pediatric rhGH Therapy: An Overview and the Need for Long-Term Surveillance
por: Cianfarani, Stefano
Publicado: (2021) -
Noonan syndrome: rhGH treatment and
PTPN11
mutation
por: Wu, Xian, et al.
Publicado: (2023)